WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $138,000 | – | 4,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coupland Cardiff Asset Management LLP | 449,361 | $15,737,000 | 15.66% |
| Sloane Robinson LLP | 120,000 | $4,202,000 | 6.01% |
| Black Creek Investment Management Inc. | 869,173 | $30,438,000 | 3.50% |
| Grandeur Peak Global Advisors, LLC | 358,385 | $12,551,000 | 3.05% |
| THOMAS WHITE INTERNATIONAL LTD | 538,212 | $18,848,000 | 2.73% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 88,460 | $3,098,000 | 1.39% |
| Granite Point Capital Management, L.P. | 70,000 | $2,451,000 | 1.22% |
| COMMONWEALTH BANK OF AUSTRALIA | 2,626,749 | $91,989,000 | 1.19% |
| Apex Capital Management | 1,048,531 | $36,720,000 | 1.11% |
| Pier Capital, LLC | 196,369 | $6,877,000 | 1.10% |